FCM MM Holdings

The proxy battle over MindMed’s (NASDAQ: MNMD) control has now evolved to each side requesting their position on what is best for the company's future to be validated by independent sources, vis-a-vis the upcoming management elections this June 15. MindMed recently...

In a new chapter of the management quarrel between MindMed (NASDAQ: MNMD) executives and shareholder group FCM Holdings, the company has published an independent report by former senior FDA officials on its clinical and regulatory plan for proprietary LSD compound and lead drug candidate, MM-...

FCM MM Holdings sent a letter to MindMed’s (NASDAQ: MNMD) board of directors calling on them to adopt a new strategic plan to "turn the company around.”  The note begins with a provocative statement: “We have seen the value of our investments in MindMed plummet as...